| Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Outline of Final Research Achievements |
The experimental study with a model eye elucidated that fundus images obtained with the Optos 200Tx was markedly stretched, especially in the peripheral regions. When the images were adjusted with a designed software, although the directions in the images were well corrected, the area was still significantly stretched in the peripheral regions.
Eyes with macular edema associated with acute central retinal vein occlusion were treated with intravitreal injections of anti-VEGF agents (1+PRN or 3+PRN regimen). Both regimen achieved a similarly rapid reduction in central foveal thickness, with subsequent improvement of visual acuity. Eyes with poor baseline visual acuity (<0.5) maintained improved VA for 1 year. Eyes with good baseline VA (>0.6) maintained baseline visual acuity for 1 year.
|
